T. Brunck

发表

Rational design and synthesis of a novel, selective class of thrombin inhibitors: P1-argininal derivatives incorporating P3P4 quaternary lactam dipeptide surrogates

R. Nutt, S. Tamura, W. Ripka, 1997 .

Guanylpiperidine peptidomimetics: potent and selective bis-cation inhibitors of factor Xa.

R. Nutt, S. Tamura, J. Ho, 2000, Bioorganic & medicinal chemistry letters.

Design, synthesis, and evolution of a novel, selective, and orally bioavailable class of thrombin inhibitors: P1-argininal derivatives incorporating P3-P4 lactam sulfonamide moieties.

R. Nutt, S. Tamura, A. Tulinsky, 1996, Journal of medicinal chemistry.

Sequence homology between acquired immunodeficiency syndrome virus envelope protein and interleukin 2.

W. Reiher, J. Blalock, T. Brunck, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Possible intermediate in the tungsten-catalyzed olefin metathesis reaction

R. Grubbs, T. Brunck, 1972 .

Rhesus monkey lipoprotein(a) binds to lysine Sepharose and U937 monocytoid cells less efficiently than human lipoprotein(a). Evidence for the dominant role of kringle 4(37).

J. Eisenbart, A. Scanu, J. Hoover-Plow, 1993, The Journal of clinical investigation.

Synthesis and biological activity of peptidyl aldehyde urokinase inhibitors.

C. A. Roberts, K. Masukawa, S. Tamura, 2000, Bioorganic & medicinal chemistry letters.

RATIONAL DESIGN, SYNTHESIS, AND SERINE PROTEASE INHIBITORY ACTIVITY OF NOVEL P1-ARGININOYL HETEROCYCLES

S. Tamura, W. Ripka, B. Shamblin, 1997 .

Design and synthesis of a novel class of thrombin inhibitors incorporating heterocyclic dipeptide surrogates

R. Nutt, S. Tamura, M. Lim-Wilby, 1997 .

Rational design, synthesis, and serine protease inhibitory activity of a novel P1-argininal derivative featuring a conformationally constrained P2–P3 bicyclic lactam moiety

S. Tamura, W. Ripka, J. E. Semple, 1997 .

Design and Synthesis of a Novel Class of Thrombin Inhibitors Incorporating Heterocyclic Dipeptide Surrogates.

R. Nutt, S. Tamura, W. Ripka, 1997 .

Investigation of the S3 site of thrombin: design, synthesis and biological activity of 4-substituted 3-amino-2-pyridones incorporating P1-argininals.

R. Nutt, S. Tamura, J. E. Semple, 1999, Bioorganic & medicinal chemistry letters.

Quantum-mechanical studies on the origin of barriers to internal rotation about single bonds

F. Weinhold, T. Brunck, 1979 .

Human T-cell leukemia virus minus strand transcription in infected T-cells.

M. Seto, T. Brunck, D. Larocca, 1989, Biochemical and biophysical research communications.

The thermoelectric power of palladium and platinum alloys

D. Greig, P. A. Schroeder, T. Brunck, 1972 .

Crystallographic structure of a peptidyl keto acid inhibitor and human α-thrombin

M. Abelman, A. Tulinsky, K. Håkansson, 1995 .

Inhibition of self-binding antibodies (autobodies) by a VH-derived peptide.

J. Blalock, T. Kieber‐Emmons, H. Kohler, 1988, Science.

Structurally homologous ligand binding of integrin Mac-1 and viral glycoprotein C receptors.

D. Altieri, T. Edgington, D. Hajjar, 1991, Science.

Synthesis and biological activity of P2–P4 azapeptidomimetic P1-argininal and P1-ketoargininamide derivatives: a novel class of serine protease inhibitors

D. Rowley, W. Ripka, J. E. Semple, 1997 .

Conceptual model of "through-bonds" interactions

F. Weinhold, T. Brunck, 1976 .

The principle of maximum overlap

F. Weinhold, T. Brunck, 1976 .

Highly selective mechanism-based thrombin inhibitors: structures of thrombin and trypsin inhibited with rigid peptidyl aldehydes.

A. Tulinsky, K. Håkansson, R. Arni, 1998, Biochemistry.

Design, synthesis, and evolution of a novel, selective, and orally bioavailable class of thrombin inhibitors: P1-argininal derivatives incorporating P3-P4 lactam sulfonamide moieties.

R. Nutt, S. Tamura, A. Tulinsky, 1996, Journal of medicinal chemistry.

Antisense peptide recognition of sense peptides: sequence simplification and evaluation of forces underlying the interaction.

Y. Shai, I. Chaiken, T. Brunck, 1989, Biochemistry.

The HTLV-III envelope protein contains a hexapeptide homologous to a region of interleukin-2 that binds to the interleukin-2 receptor.

W. Reiher, P. Hoeprich, K. Bost, 1986, Biochemical and biophysical research communications.

Synthesis, structure, and structure‐activity relationships of divalent thrombin inhibitors containing an α‐keto‐amide transition‐state mimetic

A. Tulinsky, W. Ripka, T. Brunck, 1996, Protein science : a publication of the Protein Society.